Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.41 USD | -4.43% | -4.65% | -93.88% |
04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
Number of employees: 2
Company contact information
Vallon Pharmaceuticals, Inc.
Two Logan Square 100 North 18th Street
19103, Philadelphia
+
http://www.vallon-pharma.comSector
- Stock Market
- Equities
- GRI Stock
- Company GRI BIOPAR